These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22353711)

  • 1. An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.
    de la Roche M; Rutherford TJ; Gupta D; Veprintsev DB; Saxty B; Freund SM; Bienz M
    Nat Commun; 2012 Feb; 3():680. PubMed ID: 22353711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEF1 and B9L shield β-catenin from inactivation by Axin, desensitizing colorectal cancer cells to tankyrase inhibitors.
    de la Roche M; Ibrahim AE; Mieszczanek J; Bienz M
    Cancer Res; 2014 Mar; 74(5):1495-505. PubMed ID: 24419084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
    de la Roche M; Worm J; Bienz M
    BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
    Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
    Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
    Hoffmans R; Basler K
    Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.
    Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY
    Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
    Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
    Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of a beta-catenin/BCL9/Tcf4 complex.
    Sampietro J; Dahlberg CL; Cho US; Hinds TR; Kimelman D; Xu W
    Mol Cell; 2006 Oct; 24(2):293-300. PubMed ID: 17052462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic and Self-Assembled Nanoclusters Targeting β-Catenin for Potent Anticancer Therapy and Enhanced Immunotherapy.
    Liu J; Yan J; Yan S; Wang Y; Zhang R; Hou P; He W; Ji M
    Nano Lett; 2019 Dec; 19(12):8708-8715. PubMed ID: 31744296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
    Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
    DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the interaction of BCL9 with beta-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction.
    Kawamoto SA; Thompson AD; Coleska A; Nikolovska-Coleska Z; Yi H; Wang S
    Biochemistry; 2009 Oct; 48(40):9534-41. PubMed ID: 19715304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer.
    Tanton H; Sewastianik T; Seo HS; Remillard D; Pierre RS; Bala P; Aitymbayev D; Dennis P; Adler K; Geffken E; Yeoh Z; Vangos N; Garbicz F; Scott D; Sethi N; Bradner J; Dhe-Paganon S; Carrasco RD
    Sci Adv; 2022 Apr; 8(17):eabm3108. PubMed ID: 35486727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
    Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
    Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.
    Moor AE; Anderle P; Cantù C; Rodriguez P; Wiedemann N; Baruthio F; Deka J; André S; Valenta T; Moor MB; Győrffy B; Barras D; Delorenzi M; Basler K; Aguet M
    EBioMedicine; 2015 Dec; 2(12):1932-43. PubMed ID: 26844272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors.
    Sang P; Zhang M; Shi Y; Li C; Abdulkadir S; Li Q; Ji H; Cai J
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10757-10762. PubMed ID: 31088961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Wang Z; Zhang M; Luo W; Zhang Y; Ji H
    J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
    Bian J; Dannappel M; Wan C; Firestein R
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
    Huang SM; Mishina YM; Liu S; Cheung A; Stegmeier F; Michaud GA; Charlat O; Wiellette E; Zhang Y; Wiessner S; Hild M; Shi X; Wilson CJ; Mickanin C; Myer V; Fazal A; Tomlinson R; Serluca F; Shao W; Cheng H; Shultz M; Rau C; Schirle M; Schlegl J; Ghidelli S; Fawell S; Lu C; Curtis D; Kirschner MW; Lengauer C; Finan PM; Tallarico JA; Bouwmeester T; Porter JA; Bauer A; Cong F
    Nature; 2009 Oct; 461(7264):614-20. PubMed ID: 19759537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrosomes are required for proper β-catenin processing and Wnt response.
    Vora SM; Fassler JS; Phillips BT
    Mol Biol Cell; 2020 Aug; 31(17):1951-1961. PubMed ID: 32583737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.